US Stocks Mixed; Home Depot Shares Gain After Q2 Results

Author: Avi Kapoor | August 19, 2025 09:47am

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 200 points on Tuesday.

Following the market opening Tuesday, the Dow traded up 0.50% to 45,137.22 while the NASDAQ fell 0.43% to 21,535.75. The S&P 500 also rose, gaining, 0.07% to 6,453.60.

Check This Out: Top 3 Energy Stocks That May Crash In August

Leading and Lagging Sectors

Real estate shares jumped by 1.3% on Tuesday.

In trading on Tuesday, communication services stocks fell by 1%.

Top Headline

Shares of The Home Depot Inc. (NYSE:HD) gained around 4% on Tuesday after the company released second-quarter results.

The company reported second-quarter fiscal 2025 sales of $45.277 billion, up 4.9% from $43.175 billion a year earlier, but slightly below Wall Street's estimate of $45.356 billion.

Net earnings were $4.6 billion, or $4.58 per diluted share, compared with $4.6 billion, or $4.60 per share, in the prior year. Adjusted diluted earnings per share were $4.68, just above last year's $4.67 but short of the $4.71 consensus estimate.

Equities Trading UP
           

• PainReform Ltd. (NASDAQ:PRFX) shares shot up 99% to $2.6701.
• Shares of Gaxos.ai Inc. (NASDAQ:GXAI) got a boost, surging 93% to $2.1218 after the company announced the launch of its Art-Gen.AI video creation platform.
• Laser Photonics Corporation (NASDAQ:LASE) shares were also up, gaining 76% to $4.3209 after the company reported a year-over-year increase in quarterly financial results.

Equities Trading DOWN

• Thumzup Media Corporation (NASDAQ:TZUP) shares dropped 58% to $3.58 as the company announced plans to acquire Dogehash Technologies, Inc.
• Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) were down 41% to $24.88. On Tuesday, Viking Therapeutics released the much-awaited data from its Phase 2 trial of VK2735 pill, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
• Soligenix, Inc. (NASDAQ:SNGX) was down, falling 26% to $3.6901. Soligenix recently announced it was granted FDA orphan drug designation for Dusquetide.

Commodities

In commodity news, oil traded down 0.9% to $62.86 while gold traded up 0.1% at $3,380.60.

Silver traded down 0.4% to $37.895 on Tuesday, while copper fell 0.7% to $4.4390.

Euro zone

European shares were higher today. The eurozone's STOXX 600 rose 0.7%, while Spain's IBEX 35 Index rose 0.5%. London's FTSE 100 rose 0.2%, Germany's DAX 40 gained 0.4% and France's CAC 40 rose 1.1% during the session.

Asia Pacific Markets

Asian markets closed mostly lower on Tuesday, with Japan's Nikkei 225 falling 0.38%, Hong Kong's Hang Seng falling 0.21%, China's Shanghai Composite falling 0.02% and India's BSE Sensex gaining 0.46%.

Economics

• U.S. housing starts climbed by 5.2% from the previous month to an annualized rate of 1.428 million in July.
• Building permits declined by 2.8% to an annualized rate of 1.354 million in July.

Now Read This:

• General Motors To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday

Photo via Shutterstock

Posted In: GXAI HD LASE PRFX SNGX TZUP VKTX